225 Participants Needed

Active Case Management for Domestic Violence

(SCOPE Trial)

SS
RB
Overseen ByRebecca Beebe, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Kevin Borrup
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Active Case Management for Domestic Violence?

The research on smoking cessation interventions in mental health settings shows that targeted interventions can improve care delivery and increase treatment provision, which suggests that structured approaches like Active Case Management may also be effective in managing domestic violence by improving coordination and support.12345

How does the 'Treatment as usual' for domestic violence differ from other treatments?

The 'Treatment as usual' for domestic violence, also known as Standard Care, typically involves conventional methods that are already in place, such as counseling and support services. This approach is not unique or novel, as it relies on existing practices rather than introducing new interventions or strategies specifically tailored for domestic violence.26789

Research Team

KB

Kevin Borrup, DrPH

Principal Investigator

Connecticut Children's

Eligibility Criteria

This trial is for children and teens aged 8-17 from Hartford, accompanied by a consenting parent or guardian. They must be able to assent/consent in English or Spanish and visit CT Children's during recruitment hours. Those with behavioral health issues or in DCF/police custody cannot join.

Inclusion Criteria

I can understand and agree to the study's requirements.
I am between 8 and 17 years old.
Hartford resident based on zip code of primary residence or parent report
See 3 more

Exclusion Criteria

Patients whose primary complaint is for behavioral health
Patients in Connecticut Department of Children and Families (DCF) or police custody

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive active case management to connect affected youth to community services. Families are contacted monthly by the case manager for additional support.

12 months
Monthly contacts, quarterly assessments

Follow-up

Participants are monitored for changes in violence exposure, resilience, and satisfaction with case management services.

12 months
Quarterly assessments

Treatment Details

Interventions

  • Active Case Management
  • Treatment as usual
Trial Overview The SCOPE project tests if connecting families to a Care Coordinator can reduce violence exposure. It compares 'treatment as usual' with 'Active Case Management' where coordinators actively help families navigate services.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment2 Interventions
Enrolled subjects will provide the study team with email, mobile, work phone, physical contact address, and contact numbers for two or more close contacts. Families will be contacted monthly by the case manager assist with additional supports they might need. Quarterly, patients and families will be contacted and patients will be asked to complete VPET and other measures. The intervention group will receive active case management to connect affected youth to community services.
Group II: Treatment as UsualActive Control1 Intervention
The comparison group will receive treatment as usual which consists of a list of community resources and a recommendation that youth not already connected with a community service provider be connected.

Treatment as usual is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Nicotine Replacement Therapy (NRT) for:
  • Smoking cessation
🇺🇸
Approved in United States as Bupropion (Zyban) for:
  • Smoking cessation
🇨🇦
Approved in Canada as Varenicline (Chantix) for:
  • Smoking cessation

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kevin Borrup

Lead Sponsor

Trials
1
Recruited
230+

The Tow Foundation

Collaborator

Trials
1
Recruited
230+

Findings from Research

The implementation of a smoking cessation intervention in Queensland's adult acute psychiatry inpatient units led to a sustained high rate of smoking status documentation, exceeding 90% even three years after the intervention began.
While the percentage of discharges with a completed smoking cessation intervention stabilized during the maintenance phase, the overall effectiveness of the system change intervention in addressing smoking among inpatients remained significant.
Can improvement in delivery of smoking cessation care be sustained in psychiatry inpatient settings through a system change intervention? An analysis of statewide administrative health data.Plever, S., Kisely, S., Bonevski, B., et al.[2023]
A clinical practice change intervention significantly increased the provision of nicotine dependence treatment in inpatient psychiatric facilities, with improvements in five key outcome measures over a 19-month period involving 4175 patients.
The intervention included strategies like training, leadership support, and systematic audits, leading to notable increases in clinician assessments and treatment provisions, aligning with clinical guidelines for smoking cessation.
Effectiveness of a clinical practice change intervention in increasing the provision of nicotine dependence treatment in inpatient psychiatric facilities: an implementation trial.Wye, PM., Stockings, EA., Bowman, JA., et al.[2022]
A statewide initiative in Queensland successfully increased the routine screening of smoking status among adult acute mental health inpatients from 88% to 97% over two years.
The implementation of a brief smoking cessation intervention for identified smokers also improved significantly, rising from 38% to 73%, highlighting the effectiveness of the clinical practice change in addressing smoking in mental health services.
Queensland smoking care in adult acute mental health inpatient units: Supporting practice change.Plever, S., McCarthy, I., Anzolin, M., et al.[2021]

References

Can improvement in delivery of smoking cessation care be sustained in psychiatry inpatient settings through a system change intervention? An analysis of statewide administrative health data. [2023]
Effectiveness of a clinical practice change intervention in increasing the provision of nicotine dependence treatment in inpatient psychiatric facilities: an implementation trial. [2022]
Queensland smoking care in adult acute mental health inpatient units: Supporting practice change. [2021]
Targeted Intervention to Reduce Smoking among People with Severe Mental Illness: Implementation of a Smoking Cessation Intervention in an Inpatient Mental Health Setting. [2021]
Gender differences in a randomized controlled trial treating tobacco use among adolescents and young adults with mental health concerns. [2018]
Multidisciplinary barriers to addressing tobacco cessation during an inpatient psychiatric hospitalization. [2021]
Implementing Chronic Care Model Treatments for Cigarette Dependence in Community Mental Health Clinics. [2023]
Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers. [2022]
Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security